InvestorsHub Logo
Followers 0
Posts 20
Boards Moderated 0
Alias Born 12/14/2012

Re: None

Thursday, 11/07/2013 8:56:35 PM

Thursday, November 07, 2013 8:56:35 PM

Post# of 146235
As a physician and early investor in NNVC, I have a couple of questions to ask this board. Though I'm impressed by the reports of efficacy in various viral animal models and have read that the NNVC structure is minimally toxic to its host, why has big pharma not already stepped in and provided funding? Stating that the company wants to keeps its costs low or is holding out doesn't answer the question.
Pharma is risk adverse and usually steps in and snaps up promising ideas and companies. Achieving a new paradigm for "curing" viruses will be the biggest event and potential moneymaker of this new century. What gives? What are they waiting for? Money talks. I and many physicians see this as a warning flag. There's more (or less) to this story that we can see as individual investors.

Also I still have doubts about efficacy in humans until the first tests are successful. Remember that tap water is toxic to cancer cells in a Petrie dish but obviously not so in the human body. Nature has a way of adapting and it is an unknown how we and the virus targets will respond. Don't forget that curing cancer or virus infections will radically change the world.

Hopefully it will will work as advertised and I can retire early.

Thoughts?

Ghillaman


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News